1. Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
   Toofan Datfar et al, 2021, Pathogens CrossRef
2. Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
   Yongjie Shi et al, 2023, Journal of Oncology CrossRef
3. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma
   Ting Liu et al, 2023, BMC Cancer CrossRef
4. Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities
   Disha D. Shah et al, 2023, Medical Oncology CrossRef
5. Exploring the Regulatory Role of XIST-microRNAs/mRNA Network in Circulating CD4+ T Cells of Hepatocellular Carcinoma Patients
   Lien-Hung Huang et al, 2023, Biomedicines CrossRef
6. Studies on the Role of Compartmentalized Profiles of Cytokines in the Risk of Hepatocellular Carcinoma
   Silvano Fasolato et al, 2023, International Journal of Molecular Sciences CrossRef
7. Fundamentals of Digestive Cancers Immunology, Especially Gastric and Hepatocellular CarcinomasFondamentaux de l’immunologie des Cancers Digestifs (Gastriques et Hépatocellulaires)
   Pierre-Guillaume Poureau et al, 2021, Oncologie CrossRef
8. Identification of immune cell-related prognostic genes characterized by a distinct microenvironment in hepatocellular carcinoma
   Meng-Ting Li et al, 2024, World Journal of Clinical Oncology CrossRef
9. Current Perspectives on B Lymphocytes in the Immunobiology of Hepatocellular Carcinoma
   Miaomiao Qin et al, 2021, Frontiers in Oncology CrossRef